Author Disclosure Statement
hypoglycemia, Diabetes
HYPOGLYCEMIA, DIABETES
M.E.W. reports receiving license fees from B. Braun, patents related to closed-loop, and being a consultant at CamDiab Ltd. R.H. reports receiving speaker honoraria from Eli Lilly, Dexcom, and Novo Nordisk; receiving license fees from B. Braun and Medtronic; declares consulting fees from Abbott Diabetes Care; patent issued in closed-loop field (glucose monitoring and control using multimodel approach, patent number CA2702345C) with University of Cambridge and patent issued in closed-loop field (methods for reducing false hypoglycemia alarm occurrence during closed-loop, patent number US9579456B2) with University of Cambridge and Abbott Diabetes Care; being director and stockholder at CamDiab; and leadership/fiduciary role for ATTD. A.P.V. reports advisory board fees from MSD Merck. All other authors declare no competing interests associated with this article.